Analytical laboratories continue to face confusion when distinguishing between validation, verification, and method transfer. These activities serve different purposes, yet many teams approach them as interchangeable requirements. This lack of clarity increases compliance risk and often leads to unnecessary work or gaps in regulatory justification.
In this Q&A, Kim Huynh-Ba, Editor of Analytical Testing for the Pharmaceutical GMP Laboratory, explains how to apply these concepts with intent and align with regulatory expectations.
Why do laboratories continue to struggle with the distinctions between validation, verification, and transfer?
Confusion stems from unclear intent. Validation demonstrates fitness for purpose. Verification confirms a method performed under specific lab conditions. Transfer proves reproducibility across sites. Many labs treat these as interchangeable checklists rather than purpose-driven activities. Scientists keep emphasizing what to do rather than the intended activity.
Regulatory language overlaps, and internal SOPs often lack clear definitions or decision trees. As a result, verification may expand into partial validation without justification, or transfers proceed without meaningful comparability criteria. Organizational silos add complexity as development, QC, and QA may interpret expectations differently. In addition, global organizations often apply inconsistent practices across sites.
Working in analytical science?
Register for a FREE Separation Science account to subscribe to the Separation Science Newsletter.
The fix is simple but often missing: define the objective first, then design the study. Without that, labs either over-test, under-test, or misapply requirements—creating both compliance and efficiency risks.
Under what conditions can verification legitimately replace full validation?
Verification can replace full validation when adopting a compendial or previously validated method without modification. The method must be used within its original scope—same matrix, range, and technique.
Verification should confirm key characteristics, typically precision, specificity, and (where feasible) accuracy, using actual lab conditions (equipment, analysts, materials). System suitability alone is insufficient. Any meaningful change triggers additional work. Changes in matrix, range, sample prep, or detection technique may require partial or full validation. Even minor differences (for example, column type or instrument platform) should be risk-assessed and may need bridging data. A risk-based approach is expected, especially regarding complex methods such as those for analyzing impurities and biologics. Regulators will challenge under-scoped verification.
Using United States Pharmacopeia methods does not remove responsibility—it shifts it to demonstrating suitability in your environment. Verification is appropriate when confirming performance, not redefining it.
What comparability or performance evidence do regulators expect during method transfer?
Method transfer must demonstrate comparable performance between sending and receiving sites using predefined, data-driven criteria. For critical methods (release, stability-indicating), side-by-side testing with shared samples and standards is typically expected. Acceptance criteria should align with validation characteristics, such as accuracy, precision, specificity, and be justified statistically where appropriate. Equivalence should be demonstrated using data (for example variability comparison and confidence intervals), not just pass/fail outcomes.
Transfer protocols must define approach (comparative, co-validation, or justified waiver), responsibilities, materials, and acceptance criteria. Execution should include trained analysts, qualified instruments, and controlled reagents. Discrepancies must be investigated with documented root cause and impact assessment. Poorly understood differences are a common inspection finding. Guidance in USP General Chapter <1224> only set transfer strategies, and other guides may set expectations, but regulators typically focus on scientific justification and data integrity.
